United States News All stories

Climb Bio (NASDAQ:CLYM) announced initial Phase 1 safety and pharmacokinetic data for its lead product candidate, CLYM116, at the 2026 European Renal Association (ERA) Congress in Glasgow.

G-III Apparel Group (NASDAQ:GIII), the owner and licensee of a diverse portfolio of fashion brands, reported its financial results for the first quarter of fiscal 2027, highlighting the impact of a significant regulatory refund alongside its strategic pivot toward new brand ownership.

ABM Industries (NYSE:ABM), a prominent provider of integrated facility, engineering, and infrastructure solutions, posted record revenue for its fiscal second quarter of 2026, as the company benefited from significant expansion across its core business segments.

The Board of Directors of Trane Technologies (NYSE:TT), a global leader in climate innovation, has declared a quarterly dividend of $1.05 per ordinary share.

Gilead Sciences (NASDAQ:GILD) and Lakefront Biotherapeutics (NASDAQ:LKFT) have finalized the acquisition of Ouro Medicines, a strategic move designed to bolster their respective inflammation and immunology portfolios with next-generation T cell engager therapies.

Tuniu (NASDAQ:TOUR) today announced its unaudited financial results for the first quarter of 2026, demonstrating steady growth in its core leisure travel business.

Here Group (NASDAQ:HERE) reported unaudited financial results for the third quarter of fiscal year 2026, ending March 31, 2026, revealing a challenging period characterized by softening revenue and sustained operational losses.

Kyivstar (NASDAQ:KYIV) has announced that its subsidiary, Uklon, has signed a definitive agreement to acquire E-wings, a prominent Ukrainian operator of electric scooters and micromobility solutions.

Gilead Sciences (NASDAQ:GILD) has formally recognized the South African government’s leadership in accelerating the nationwide rollout of lenacapavir, a long-acting injectable medication designed for HIV pre-exposure prophylaxis (PrEP).

Target (NYSE:TGT) has initiated a nationwide voluntary recall of its proprietary Up & Up brand baby wipes, citing the potential for microbial contamination that poses significant health risks to consumers.

A months-long dispute between the Trump administration and AI firm Anthropic is showing signs of cooling as the company navigates the final stages of its preparation for a highly anticipated initial public offering.

Global oil prices showed stability on Friday as market participants parsed conflicting signals from the Middle East.

Guidewire Software (NYSE:GWRE) reported strong financial results for its fiscal third quarter ended April 30, 2026, delivering a 27% year-over-year revenue increase to $372.5 million.

Planet Labs (NYSE:PL), a leading provider of daily geospatial data and insights, reported record revenue of $94.2 million for its fiscal first quarter ended April 30, 2026.

DocuSign (NASDAQ:DOCU) reported financial results for its first quarter of fiscal year 2027 ended April 30, 2026, delivering performance that surpassed market expectations.

The U.S. Supreme Court delivered a significant victory to the Federal Communications Commission (FCC) on Thursday, June 4, 2026, ruling that the agency's internal system for imposing financial penalties—known as "forfeiture orders"—does not violate the Seventh Amendment right to a jury trial.

Pinterest (NYSE:PINS) today announced a major expansion of its long-standing collaboration with Amazon Web Services (AWS), entering into a planned $4 billion commitment for cloud services through 2031.

The Board of Directors of Nordson (NASDAQ:NDSN) has declared a cash dividend of $0.82 per common share for the third quarter of fiscal year 2026.

MIRA Pharmaceuticals (NASDAQ:MIRA) announced that it has executed an Amended and Restated Exclusive License Agreement with MIRALOGX.

Xenetic Biosciences (NASDAQ:XBIO) announced today that its collaboration partner, PeriNess, has received formal approval from the Israeli Ministry of Health and the relevant Institutional Review Board to initiate an exploratory clinical study.

Teva Pharmaceutical (NYSE:TEVA) announced the launch of AHZANTIVE (aflibercept), a biosimilar to Eylea, across several major European markets, including France, Germany, Spain, and the Netherlands.

GameSquare Holdings (NASDAQ:GAME) issued a shareholder update today projecting significant growth for the second quarter of 2026.

The Toro Company (NYSE:TTC) reported strong financial results for its fiscal second quarter ended May 1, 2026, as the company benefited from sustained demand across its professional and residential segments during the critical spring selling season.

IQSTEL (NASDAQ:IQST) announced today that it has signed a binding Memorandum of Understanding (MOU) to acquire a 51% controlling interest in Ultranet Telecom Group.